Please assess the completion status of the following clinical trial:

Trial Title: Pilot Study of Ketamine in Adults With Obsessive-Compulsive Disorder (OCD)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18-55~* Physically healthy and not currently pregnant~* Primary Diagnosis of OCD~* Sufficient severity of symptoms~* Able to provide consent~Exclusion Criteria:~* Psychiatric conditions that make participation unsafe~* Currently on psychotropic medication~* Medical conditions that make participation unsafe~* Allergy to ketamine~* Any metal in the body

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Study Arms:
- Group A (Type: ACTIVE_COMPARATOR): 0.5mg/kg IV ketamine infusion over 40 minutes then IV saline infusion over 40 minutes
- Group B (Type: ACTIVE_COMPARATOR): IV saline infusion over 40 minutes then 0.5mg/kg IV ketamine infusion over 40 minutes

Based on this trial design, predict the completion outcome and termination type (if applicable).